TLR4 Gene Variants and Hepatocellular Carcinoma Risk
Author Information
Author(s): Minmin Shi, Xiaoqian Xu, Hao Chen, Baiyong Shen, Xiaxing Deng, Junjie Xie, Xi Zhan, Jianquan Zhao, Songyao Jiang
Primary Institution: Research Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Hypothesis
Single-nucleotide polymorphisms of TLR4 are associated with hepatocellular carcinoma susceptibility.
Conclusion
The study found that certain TLR4 gene variants may decrease the risk of developing hepatocellular carcinoma.
Supporting Evidence
- Six TLR4 SNPs were associated with decreased risk of hepatocellular carcinoma.
- Individuals with heterozygous genotypes had significantly lower odds of developing the cancer.
- The haplotype GCCCTTAG was significantly associated with reduced risk of hepatocellular carcinoma.
Takeaway
Some changes in a gene called TLR4 can help protect people from getting liver cancer.
Methodology
A case-control study analyzed ten single-nucleotide polymorphisms in 216 hepatocellular carcinoma cases and 228 controls.
Potential Biases
Potential selection bias due to the case-control design.
Limitations
The study was conducted at a single center and involved a specific population, which may limit generalizability.
Participant Demographics
Participants were unrelated Han Chinese individuals.
Statistical Information
P-Value
p<0.01
Confidence Interval
0.407–0.758
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website